Advertisement
Singapore markets closed

  • Straits Times Index

    3,297.55
    -26.98 (-0.81%)
     

  • Nikkei

    38,814.56
    +94.09 (+0.24%)
     

  • Hang Seng

    17,941.78
    -170.85 (-0.94%)
     

  • FTSE 100

    8,146.86
    -16.81 (-0.21%)
     

  • Bitcoin USD

    66,141.72
    -143.91 (-0.22%)
     

  • CMC Crypto 200

    1,371.12
    -46.75 (-3.30%)
     

  • S&P 500

    5,431.60
    -2.14 (-0.04%)
     

  • Dow

    38,589.16
    -57.94 (-0.15%)
     

  • Nasdaq

    17,688.88
    +21.32 (+0.12%)
     

  • Gold

    2,348.40
    +30.40 (+1.31%)
     

  • Crude Oil

    78.49
    -0.13 (-0.17%)
     

  • 10-Yr Bond

    4.2130
    -0.0250 (-0.59%)
     

  • FTSE Bursa Malaysia

    1,607.32
    -2.85 (-0.18%)
     

  • Jakarta Composite Index

    6,734.83
    -96.73 (-1.42%)
     

  • PSE Index

    6,383.70
    -7.13 (-0.11%)
     

Theratechnologies Reports on its Annual Meeting of Shareholders

Theratechnologies
·2-min read
Theratechnologies
Theratechnologies

MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting.

Shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term and appointed KPMG LLP as the Company’s auditors for the current fiscal year. All candidates proposed for the position of director were elected in the following proportion:

 

FOR

% FOR

ABSTENTION

% ABSTENTION

Joseph Arena

22,405,047

 

93.09

%

1,663,754

 

6.91

%

Frank Holler

21,008,601

 

87.29

%

3,060,200

 

12.71

%

Paul Lévesque

20,966,427

 

87.11

%

3,102,374

 

12.89

%

Andrew Molson

21,067,050

 

87.53

%

3,001,751

 

12.47

%

Dawn Svoronos

20,964,213

 

87.10

%

3,104,588

 

2.90

%

Elina Tea

21,734,254

 

90.30

%

2,334,547

 

9.70

%

Dale Weil

21,009,681

 

87.29

%

3,059,120

 

12.71

%

Jordan Zwick

23,107,383

 

96.01

%

961,418

 

3.99

%

Frank Holler will now act as Chair of the Board of Directors of the Company.

ADVERTISEMENT

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter).

Contacts:

Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
pdubuc@theratech.com
1-438-315-6608

Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800